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Background: Histone isoforms and their post-translational modifications (PTMs) play an important role in the
control of many chromatin-related processes including transcription and DNA damage. Variants of histones H2A
and H3 have been studied in depth and have been found to have distinct functions. Although 13 somatic histone
H2B isoforms have been identified by various biochemical and mass spectrometric (MS) approaches, the distinct
roles of these isoforms within human cells are as yet unknown. Here, we have developed quantitative MS techniques
to characterize isoform-specific H2B expression across the cell cycle, in differentiated myogenic cells, and in different
cancer cell lines to illuminate potential functional roles.
Results: Using the MS strategies that we developed, we identified differences in H2B isoform levels between different
cancer cell types, suggesting cancer or tissue-specific H2B isoform regulation. In particular, we found large variations
in the levels of isoforms H2B1B and H2B1M across the panel of cell lines. We also found that, while individual H2B
isoforms do not differ in their acetylation levels, trends in the acetylation on all H2B isoforms correlated with acetylation
on other histone family members in the cancer cell line panel. We also used the MS strategies to study H2B protein
expression across the cell cycle and determined that H2B isoforms that are alternatively spliced to carry a polyadenylation
signal rather than the standard histone downstream element are expressed independently of the cell cycle. However,
the level of protein produced from the polyadenylated transcripts does not contribute significantly to the total pool of
H2B isoforms translated across the cell cycle or in non-cycling myogenic cells.
Conclusions: Our results show that H2B isoforms are expressed at varying levels in different cells, suggesting
isoform-specific, and possibly cell-type-specific, H2B gene regulation. The bottom-up mass spectrometry technique
we developed for H2B quantification is compatible with the current standard histone H3 and H4 bottom-up
‘one-pot’ analysis platform so that H2B isoforms and their modifications can be studied in future experiments at
the same time as histone H3 and H4 modifications. Therefore, we have expanded the histone landscape that can
be interrogated in future experiments.Background
Histones and 147 base pairs of DNA are together the
building blocks of nucleosomes, which form the basic re-
peating units of chromatin. Chromatin is further folded
and packaged into higher order structures with increasing
degrees of compaction [1]. How tightly chromatin is pack-
aged influences how accessible it is to DNA binding pro-
teins, including transcription factors and DNA repair
proteins [2]. Histones play important roles in regulating* Correspondence: bgarci@mail.med.upenn.edu
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unless otherwise stated.chromatin structure and function through dynamic post-
translational modifications (PTMs) and specialized his-
tones called histone variants.
There are five types of histone proteins: H2A, H2B,
H3, H4, and H1, and with the exception of H4, all have
multiple isoforms [3]. These isoforms are proteins en-
coded by separate genes that have the same core histone
structure with some sequence variation [4]. Variants differ
from canonical histones in their protein-protein inter-
actions, localization in chromatin, number and types of
PTMs, nucleosome stability, and tissue-specific expression
profiles [5]. All of these differences lead to unique func-
tions for histone variants compared to canonical histones.
Histone variants are expressed in a DNA replication-l. This is an Open Access article distributed under the terms of the Creative
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throughout the cell cycle, and are incorporated into nu-
cleosomes outside of S-phase [3,6]. Some new histone
variants have been discovered recently, but the most
well-characterized core histone variants include H3.3,
CENP-A, H2A.Z, H2A.X, and macroH2A [3]. Loss of
function of any of these histone variants leads to acute
consequences in specific cellular and developmental pro-
cesses, such as fertility, proper centromere formation,
genome integrity, and the DNA damage response [3].
Knockouts of variants H2A.Z and H3.3 are lethal in mice,
and H2A.Z-knockdown embryonic stem cells have a de-
creased efficiency in self-renewal and differentiation [7-9].
Most of the knowledge about histone variant functions
comes from studies on H2A and H3, but very little is
known about H2B isoforms. H2A and H3 isoforms have
important functions in chromatin biology, and since
there are so many H2B isoforms, it is likely that some of
the H2B isoforms have unique functions. There are 16
isoforms of H2B in humans (Figure 1), 13 of which are
expressed in somatic cells [10-12], and 3 of which are
testis-specific [13,14]. The only human isoforms that have
been studied in depth so far are the testis-specific variants
H2BFWTand H2B1A [13,14].
Somatic human H2B isoforms are all encoded by genes
located in histone cluster 1 on chromosome 6 (6p21-6p22),
and in cluster 2 (1q21) and cluster 3 (1q42) on chromo-
some 1, and produce mRNA with characteristic 3′ stem-
loop sequences and histone downstream elements [15].
H2B genes in the gene clusters are arranged in pairs with
divergent H2A sequences that have a shared promoterFigure 1 Points of sequence variation and modifications on human H2B isof
Sites of sequence variation are in bold. (B) Sequence alignment of H2B isofor
isoforms are listed in red, and testis-specific variants are in blue. Variants H2BF
entire sequences. Me =methylation, Ac = acetylation, Ph = phosphorylation, Gregion [16]. The histone genes inside of these clusters are
all expressed at high levels during S-phase due to stabi-
lization of transcripts with 3′ stem-loops [17]. Although
expression of genes within the histone clusters is coordi-
nated during the cell cycle, individual H2B (and H2A)
genes are regulated by different promoter sequences and
are expressed at different levels [15,16]. Somatic human
H2B isoforms have very little sequence variation - they
differ by as few as two amino acids and up to five amino
acids (Figure 1). Most of the changes in sequence are
small, but a few could affect protein function. For in-
stance, the proline-to-leucine conversion in H2B1L would
change the structure of the H2B N-terminal tail. In
addition, there are many serine-and-threonine-to-alanine
conversions in H2B isoform sequences, including at S36
in H2B3B, a site that is important in cell stress response
regulation [18]. This serine-to-alanine difference occurs at
the DNA-histone contact and could therefore poten-
tially change nucleosome structure. In addition, differ-
ences in amino acid sequence could also be involved in
isoform-specific protein-protein interactions. Small dif-
ferences in known histone variants are responsible for
variant-specific chaperone and chromatin remodeling en-
zyme recognition [19,20].
There is evidence for somatic H2B sequences having
unique functions in other organisms. H2B variants in
Trypanasoma brucei and in Plasmodium falciparum
form dimers specifically with the H2A variant H2AZ
and localize to active genes [21,22]. Most recently, it was
discovered that the H2B variant H2BE is involved in
controlling olfactory gene expression in mice, suggestingorms. (A) Modification sites on the H2B N-terminal tail and C-terminal tail.
ms. Points of sequence variation are highlighted in purple. Somatic
M and H2BFWT differ significantly from other H2B isoforms across their
= glycosylation, Ub = ubiquitination.
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roles [23]. This H2B variant has an analogous sequence
in humans (H2B1L). In fact, H2B sequence variation is
conserved among higher eukaryotes [24], and some of
the variants characterized in other organisms may have
counterparts with similar functions in human cells.
The sequence similarity between histone H2B isoforms
makes it challenging to differentiate between isoforms at
the protein level. Mass spectrometry (MS) methods for
identifying histone proteins include top-down MS of
intact proteins, middle-down MS of large peptides, and
bottom-up MS of smaller peptides. Two previous inves-
tigations, by Siuti et al. and Bonenfant et al., used top-
down and bottom-up MS to identify H2B isoforms in
human cell lines [10,11]. Siuti et al. used top-down to
identify 8/13 H2B isoforms; they also used l-methionine-
methyl-13C-methyl-d3 to label potential methylation sites
and histone deacetylase inhibitors to increase levels of
H2B acetylation. They found no evidence of H2B methy-
lation but did identify two acetylation sites on the most
abundant H2B isoform [11]. Bonenfant et al. used a var-
iety of protease digest methods, including Glu-C digests,
to identify 11 histone H2B isoforms and 3 acetylation
sites [10]. These studies confirmed that many H2B
isoforms are present at the protein level for the first
time but failed to detect some lower abundance H2B
isoforms.
To date, methods to comprehensively, consistently, and
quantitatively analyze histone H2B isoforms and their
post-translational modifications have not been thoroughly
compared and established. Here, we describe top-down
and bottom-up mass spectrometry methods we developed
to identify all 13 known H2B isoforms. The bottom-up
method, unlike previous strategies, uses a well-established
chemical derivatization method to create H2B N-terminal
peptides of a similar and consistent length that can be
resolved reproducibly using reversed-phase chromatog-
raphy. As a result, this method can be used to quantify the
9 out of 13 somatic H2B isoforms that have unique
N-terminal sequences and their modifications.
Since there is little research on potential biological
differences between somatic H2B isoforms, we used the
mass spectrometry methods developed to profile H2B iso-
form levels from mammalian cells. These top-down and
bottom-up MS methods were utilized to profile the H2B
isoform composition of different cancer cells. If H2B iso-
forms are regulated differently across cell types, then
it is possible that some isoforms have unique cell-
type-specific functions. We also used these methods to
determine whether some H2B isoforms are expressed
independently of DNA replication and to determine
whether there are differences in the rates of synthesis of
H2B variants between proliferating and terminally dif-
ferentiated cells.Results
Top-down MS analysis of H2B
Top-down mass spectrometry of intact proteins is essen-
tially the only method that can distinguish between all of
the histone H2B isoforms and their PTMs, as it is the
only approach that retains complete sequence informa-
tion. We purified histone H2B from acid-extracted his-
tones using C18-based reversed-phase chromatography
(Figure 2A), then infused the purified H2B directly into
the mass spectrometer and collected spectra to deter-
mine the intact masses of the H2B isoforms. Peaks from
the H2B intact mass spectrum were then fragmented
using electron transfer dissociation (ETD) for sequence
analysis. We used ProSightPTM2.0 [25] and the MASH
suite [26] programs as well as manual annotation to de-
convolute masses from the H2B MS1 intact mass spectra
and to identify H2B isoforms and sites of post-translational
modifications from the ETD MS/MS spectra.
There are six main peaks in the intact mass spectrum
of histone H2B (Figure 2A). The 5 most abundant
masses match the predicted masses for 11 out of 13
known H2B isoforms (Figure 2A), as well as the monoa-
cetylated forms of 3 H2B isoforms (H2B2F, H2B1D, and
H2B1C) and the di-acetylated form of 2 isoforms (H2B1C
and H2B1D). The low-mass peaks next to the main H2B
peaks are artifacts caused by signal processing in the mass
spectrometer. All of the H2B isoforms expressed in human
somatic cells are the same length and have very few points
of sequence variation. Consequently, many of them have
the same intact mass or masses that are similar enough
that they cannot be resolved based on the full-MS spectra
alone (Additional file 1: Table S1). We identified these spe-
cies at the MS/MS level using distinguishing c and z ions
in their ETD fragmentation spectra. For example, histone
H2B1K and histone H2B1H are proteins with masses that
differ by only 2 Da and as a result have almost completely
overlapping isotopic peak clusters. They differ in se-
quence by one amino acid at position 2 and at position
125 (Figure 1A). This sequence difference leads to unique c
and z ion series for the two H2B isoforms (Figure 2B) in
their combined fragmentation spectra. We did not detect
two H2B isoforms (H2B3B, H2B1L) using top-down MS,
despite prior evidence for these forms from real-time (RT)-
PCR experiments [12]. These isoforms have similar masses
to the most abundant H2B isoforms, so it is possible that
their signal was masked by the more abundant species. We
estimated abundances of the isoforms and modified forms
based on the protein ion relative ratios (PIRRs) using the
five most abundant isotopic peaks for each isotopic cluster
(Additional file 1: Table S1) as described previously [27].
Bottom-up MS analysis of H2B
Top-down MS is a powerful technique that can distin-
guish between the majority of H2B isoforms and their
Figure 2 Top-down MS of histone H2B isoforms. (A) Intact mass spectrum of HPLC-purified Jurkat H2B at the most abundant charge state, z = 17.
H2B isoforms were identified based on MS/MS spectra and intact mass. Ac = acetylation. (B) Fragmentation spectrum of H2B isoforms H2B1K and
H2B1H. Identified c and z ions are marked in blue (H2B1H) and red (H2B1K), respectively. The sequences at the top of the figure illustrate the
extent of sequence coverage based on identified c and z ions. The inset shows magnified spectra of select c and z ion peak pairs for H2B1H and
H2B1K, respectively.
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less quantitative than other MS strategies. We developed
bottom-up MS techniques to quantify and to identify
H2B isoforms that were not abundant enough to be de-
tected by top-down MS. As with other histone proteins,
histone H2B is very lysine and arginine rich, making it
difficult to digest with standard proteases and also mak-
ing its digested fragments very hydrophilic and therefore
not as compatible with standard reversed-phase C18-
based chromatography as frequently utilized in proteo-
mics experiments.We analyzed H2B by derivatizing it first with propio-
nic anhydride to cap primary amines on lysine residues
with propionyl groups. This is a standard chemical de-
rivatization technique that our lab uses to process his-
tones [28], but we had not applied it yet to study H2B
isoforms and their modifications. Capping the lysines
prevents their digestion with trypsin so that the se-
quence is only digested after arginine in an Arg-C-like
manner but with much more efficiency and specificity
than using Arg-C itself. Propionylation also increases the
hydrophobicity of histone peptides and thereby improves
Molden et al. Epigenetics & Chromatin  (2015) 8:15 Page 5 of 17their retention and resolution on reversed-phase columns.
Digesting after arginine creates a 29-amino-acid-long H2B
N-terminal peptide encompassing the entire H2B N-
terminal tail, the part of the H2B sequence with the most
sequence diversity and modifications. It also creates a pep-
tide encompassing the H2B C-terminal tail - the site of an
important ubiquitination PTM [29].
The H2B(1–29) peptide created using this method is
longer than the histone peptides that we usually analyze,
and it contains 11 propionylated lysine residues, making
it more hydrophobic. We were concerned about finding
an appropriate fragmentation technique that would give
us a complete ion series covering the entire tail sequence
so that we could confirm sites of modification and se-
quence variation. We analyzed propionylated H2B peptides
using three different fragmentation methods: collisionally
activated dissociation (CAD), higher energy collisional dis-
sociation (HCD), and ETD (Figure 3). All of these fragmen-
tation methods created complete, or nearly complete, ion
series across the H2B(1–29) peptide; however, each frag-
mentation method had a different optimal charge state.
There were three abundant charge states of the H2B(1–29)
peptide: the most abundant species is +4, followed by +3,
and then +5.
CAD spectra were optimal for analyzing the N-terminal
peptide sequence (Figure 3C). Fragmentation of both
the +4 and +3 charge-state species created complete or
nearly complete y-ion and b-ion series. There was a par-
ticularly strong y + 2 ion series for this peptide, with
the most abundant fragment ions occurring on the N-
terminal side of prolines. This proline-directed fragmenta-
tion was advantageous because it captures the sequence
diversity of the H2B tail. This set of ions can be used to
easily identify and distinguish between H2B isoforms. For
example, the monoacetylated H2B1D N-terminal and
the H2B1N N-terminal tail have different sequences
but the same mass. The peaks can be distinguished from
each other based on the characteristic proline-directed
fragments in their MS/MS spectra (Additional file 2:
Figure S1A and B).
After analyzing propionylated H2B samples, we identi-
fied H2B(1–29) N-terminal tail sequences representing
seven unique H2B isoforms and two tail sequences that
were shared between the remaining six H2B isoforms. In
addition, each N-terminal tail sequence had up to a total of
four lysines modified with acetyl groups (K5, K12, K15,
K20). The most commonly acetylated residues, as deter-
mined by their unique fragment ion intensities, were lysine
12 and 15, which is in agreement with previous research
which quantified H2B acetylation by Western blot [30].
We also identified a potential new N-terminal H2B ubi-
quitination site at lysine 5 (Additional file 2: Figure S1),
in addition to the more commonly studied C-terminal
H2B(K123) ubiquitination site [29].All of the unique H2B N-terminal tails, except for the
nearly isobaric isoforms H2B3B and H2B1C, and their
acetylated forms were chromatographically resolved on a
C18-column after propionylation (Figure 4A). In addition,
the H2B N-terminal tails elute later than most other
histone peptides due to their size, making it possible to
analyze H2B at the same time as histones H3 and H4
from an unfractionated histone preparation. Such separ-
ation enables quantification of H2B isoforms by peak in-
tegration of the extracted ion chromatograms for each
N-terminal peptide mass. We divided the sum of the
peak areas for each form by the total detected signal for
all N-terminal tail peptides to give the relative abun-
dances of each H2B isoform. The relative abundances
for different H2B isoforms extracted from HeLa samples
are given in Figure 4B. The relative abundance of
H2B3B was quantified separately using a different pep-
tide (EVQTAVR) that is unique to H2B3B. This method
of quantification is very consistent, as demonstrated by
the small standard error in relative abundance for each
isoform, derived from five different HeLa samples that
were run on different days and on different instruments
and which were from separate histone preparations
(Figure 4B). The relative abundance of acetylation on
each H2B isoform can be obtained in a similar manner.
These results show that the levels of acetylation do not
differ significantly across H2B isoforms (Additional file 3:
Figure S2).
Profiling H2B isoform composition in commonly used
cancer cell lines
Previous studies have demonstrated that there is vari-
ation in the expression of the mRNA of different H2B
isoforms across cancer cell lines [12,31]. This suggests
that there may be different abundances of H2B isoform
proteins between cell lines and possibly cell-type-specific
functions for the different H2B isoforms. Also, some
H2B transcripts are frequently overexpressed in certain
cancer types, so we would therefore expect to see some
variations in their protein abundances as well [32,33].
We used top-down MS and bottom-up MS to confirm
differences in H2B isoform protein levels across different
cell lines, including a catalog of cancer cell lines that
represent many different cell types and cancer types.
Top-down MS was used to confirm that there are dif-
ferences in the levels of H2B isoforms across cancer cell
lines (Additional file 4: Figure S3). Relative to the most
abundant H2B1C/1 J/1O peak, we found the most vari-
ation in the H2B1H/H2B1K, H2B2E/2 F, and H2B1M
levels. However, the top-down MS results were not as
quantitative as the bottom-up results, and we were un-
able to deconvolute isobaric species contributions to the
differences in abundances that we observed. So once we
confirmed differences in H2B levels at the protein level
Figure 3 Comparison of MS/MS fragmentation methods for the propionylated H2B N-terminal tail. (A) ETD fragmentation spectrum of the
H2B1D(1–29) sequence. (B) HCD fragmentation of the H2B1D(1–29) sequence. (C) CAD fragmentation spectrum of the H2B1D(1–29) sequence.
CAD = collisionally activated dissociation, ETD = electron transfer dissociation, HCD = higher energy collisional dissociation.
































Figure 4 Propionylated H2B N-terminal tail chromatography and quantification. (A) H2B isoform N-terminal tails can be chromatographically
resolved after propionylation. The top panel is the base peak chromatogram, and each of the following panels is an extracted ion chromatogram
for different N-terminal peptide masses. Isobaric species such as H2B1D and H2B1B were completely resolved. (B) Relative quantification of H2B
isoforms in HeLa samples. Mean ± SE, n = 5.
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cancer cell lines using the bottom-up MS technique
described in the previous section.
We determined the relative abundances of H2B iso-
forms (Figure 5), and acetylation levels (data not shown),
across 20 cell lines representing different cell types using
bottom-up MS. This panel of cell lines had previously
been used to profile histone H3 and H4 PTMs [34]. Thepanel consisted of mostly cancer cell lines but also in-
cluded human foreskin fibroblast (HFF) and human em-
bryonic HES-2 cells. HFF and HES-2 are non-cancerous
cell lines and have normal chromosome numbers and so
can be used as reference samples where H2B isoform
levels would not be influenced by chromosomal abnor-
malities. To compare H2B isoform abundances, we nor-
malized the relative abundance for each isoform to the
Figure 5 Hierarchical clustering of H2B isoform abundances across 20 cell lines. The relative abundances of H2B isoforms were determined using
bottom-up MS, normalized against the average abundance for each isoform across all cell lines and log2 transformed. Data for H2B3B was excluded
from the analysis because the characteristic H2B3B peptide (EVQTAVR) was missing from many MS runs due to poor chromatography at the beginning
of the LC-MS gradient. The remaining H2B isoforms were quantified for each cell line based on the H2B(1–29) tail sequence and had CV < 30%,
n = 3 or 4.
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lines. We then clustered cell lines with similar H2B iso-
form profiles using hierarchical clustering with Euclidian
distance as a metric.
Similar to the top-down cancer cell line data, we
observed differences in H2B isoform levels across the
different cell lines (Figure 5). Cell lines from the same
cell type clustered together. The only exceptions were
the prostate cell lines PC3 and DU145 and the skin cell
lines HaCAT (keratinocyte) and HFF (fibroblast), which
had very different H2B isoform profiles. The most strik-
ing difference between cancer cell lines was in the levels
of isoforms H2B1B and H2B1M. HFF and hES2 cells
had higher levels of both isoforms compared to most of
the cancer cell lines. In addition, one third of the cell
lines profiled had significantly lower levels of H2B1B
than the rest of the cell lines. Other H2B isoforms that
varied in abundance between cell types, but did not
show as striking differences as H2B1B and H2B1M, are
H2B2F and H2B1L.
Most cell lines had very similar levels of H2B acetyl-
ation (approximately 11% of the total signal on average).
The exceptions were hES2, Jurkat, and C33a cells, whichhad higher levels of acetylation (23%, 18%, and 22%,
respectively, of the total signal), and SW480 cells, which
had lower (6%) levels of acetylation. This result is con-
sistent with a study from our lab that used the same
cancer cell line data to analyze histone H3 and H4 modi-
fications that also found high levels of histone acetylation
in hESC and C33a cells [34]. The low levels of H2B acetyl-
ation in SW480 cells are in agreement with a previous
study, which found that overexpression of RGC-32 in
SW480 suppressed H2BK5 acetylation [35].
Polyadenylated H2B mRNA and protein levels in the cell
cycle and in terminally differentiated cells
Histone levels are very tightly regulated; in fact, excess
histone synthesis is detrimental and leads to chromo-
some abnormalities and cell death [36,37]. Histone vari-
ants, such as macroH2A, H2A.Z, and H3.3, that are made
outside of DNA replication have specific functions [3,7].
Polyadenylated H2B transcripts accumulate following
p53-induced senescence and during terminal cell differen-
tiation [12]. Therefore, we wanted to determine whether
the polyadenylated H2B mRNA is expressed in a cell-
cycle-independent manner and whether this leads to an
Molden et al. Epigenetics & Chromatin  (2015) 8:15 Page 9 of 17increase in the levels of these proteins outside of S-phase.
If these H2B isoforms are produced outside of S-phase,
then it is possible that they have unique functions as
replacements for canonical H2B. In addition, it is possible
that H2B isoforms produced outside of S-phase associate
with other replication-independent variants when they are
assembled into chromatin. We hypothesized that polyade-
nylated H2B sequences would be expressed in a cell-cycle-
independent manner. In order to test this hypothesis, we
designed primers against the histone H2B1D coding se-
quence and against the polyadenylation sequence. We
synchronized cells and synthesized cDNA from mRNA
collected during G1- and S-phases then compared the
relative amount of mRNA across these cell cycle phases
using quantitative real-time (q-RT)-PCR.
The results of this experiment are shown in Figure 6.
Cell cycle synchronization was validated by flow cytome-
try analysis (Additional file 5: Figure S4). The q-RT-PCR
data was normalized against 18S rRNA. We analyzed the
expression of polyadenylated H2B1D (H2B1DpA) and all
H2B1D transcripts (H2B1D), as well as the expression of
a known replication-dependent histone variant (H3.1), a
known replication-independent histone variant (H3.3),
and a histone H2B isoform with no polyadenylation signal
(H2B1C) as controls (Figure 6). The results show that the
replication-dependent histones H2B1C, H3.1, and H2B1D
are expressed at much higher levels in S-phase compared
to G1-phase, as expected. The replication-independent


















Figure 6 Polyadenylated histone isoforms show no changes in
levels across the cell cycle. H2B mRNA relative expression in S-phase
of the cell cycle compared to G1-phase. Canonical histones (H2B1C,
H2B1D, H3.1) have much higher relative expression during S-phase
compared to G1 than replication-independent histones (H3.3) and
polyadenylated H2B1D. H2B1D results are from primers against the
H2B1D coding sequence, and H2B1DPa results are from primers
against the polyadenylation sequence. mRNA was synthesized using
random hexamers and analyzed by q-RT-PCR. Bars marked with a ‘*’
indicate a P value <0.01, indicating that that histone variant was
expressed at significantly higher levels in S-phase than G1-phase.
Mean ± SD, n = 3.between the different phases of the cell cycle. As we hy-
pothesized, the polyadenylated form of histone H2B1D
showed a very similar trend to H3.3 expression through-
out the cell cycle with very little variation between G1-
and S-phases. Histone H2B1K is another H2B isoform
that can be polyadenylated. We did not design primers
against the polyadenylated form of H2B1K, but it showed
less cell cycle variation with primers that recognize all
H2B1K forms than other histone mRNA.
We wanted to confirm that the cell-cycle-independent
expression of polyadenylated H2B mRNA also leads to
cell-cycle-independent production of H2B proteins. If
there is a significant expression of mRNA of specific
H2B isoform outside of S-phase, then these isoforms
should be made throughout the cell cycle. To test this,
we pulse-labeled cells with heavy arginine (13C6
15N4-
Arginine) to track histone synthesis before and after
blocking cells in S-phase (Figure 7A). The heavy arginine
is incorporated into newly synthesized proteins, resulting
in a 10-Da mass shift between new and old histone pep-
tides (Figure 7B). First, HeLa cells were grown for one
doubling time (24 h) in heavy arginine media so that half
of the histones were labeled. At this point, we added ex-
cess thymidine to the growth media, which prevents DNA
synthesis and blocks cells in S-phase. This block should
also prevent replication-dependent histone synthesis, but
not replication-independent synthesis. Therefore, after the
thymidine block, replication-independent histones should
continue to incorporate heavy arginine, but replication-
dependent histones will not.
As expected, the known replication-independent histone
variant H2A.Z continued to incorporate heavy arginine at
the same rate after the thymidine block (Figure 7B) as be-
fore. Other replication-independent variants such as his-
tone H1.x showed similar trends (data not shown). Heavy
arginine incorporation for replication-dependent H2A
(H2A2B) and H2B (H2B1C, H2B1L, H2B1M) histone iso-
forms with no known polyadenylation signal leveled off
after the thymidine block close to the expected 1:1 heavy-
to-light ratio. There was still some incorporation of heavy
arginine because a portion of the cells was not completely
synchronized after one thymidine block. The H2B isoform
with a known polyadenylation signal, H2B1D, showed a
trend that was indistinguishable from other replication-
dependent histone isoforms. This indicates that the polya-
denylated H2B1D mRNA did not contribute significantly
to the H2B1D protein levels after the thymidine block.
Studies have shown that polyadenylated replication-
dependent variants such as histone H2B1D and H2A1C
are present at very low levels in normal cycling cells but
increase in terminally differentiated cells or senescent cells
[12,38,39]. It has been suggested that polyadenylated his-
tone variants are required in these non-replicating cells
to maintain chromatin integrity [7,39]. In order to test
Figure 7 Heavy arginine incorporation into newly synthesized histones before and after blocking HeLa cells in S-phase using thymidine. (A) Cells
were grown in heavy media for 24 h or one doubling so that the ratio of new-to-old histone (heavy-to-light) should be 1:1. They were then
blocked with thymidine. Time points were collected, and histones were analyzed using bottom-up MS. (B) MS1 spectra of H2B1C/2E/1 J/1 K(1–29),
H2B1D(1–29), and H2A.Z(35–40) showing increase in heavy-labeled ‘new’ protein over time. H2B1D(1–29) and H2B1C(1–29) synthesis is blocked,
and so, the proteins stopped incorporating heavy arginine after the double-thymidine block at 24 h. The synthesis of replication-independent H2A.Z
continued after the double-thymidine block. (C) Plot of heavy arginine incorporation over time for replication-dependent and replication-independent histone
isoforms. H2A.Z (blue) is a known replication-independent isoform, and H2A2B is a replication-dependent isoform (red). The replication-independent
H2A.Z isoform continues to incorporate heavy arginine following the thymidine block, but replication-dependent histones stop incorporating the label.
Molden et al. Epigenetics & Chromatin  (2015) 8:15 Page 10 of 17whether elevated polyadenylated histones levels in termin-
ally differentiated cells are incorporated into chromatin, we
labeled human myoblast and myotube cell cultures with
(13C6
15N4-Arginine) over the course of 7 days (Figure 8,
Additional file 6: Figure S5). We also analyzed the expres-
sion of different histone variant mRNAs, including polya-
denylated H2B1D mRNA, in myotubes versus myoblasts
by quantitative RT-PCR. Myotubes are non-cycling cellsthat are known to have higher levels of replication-
independent variants than their proliferating progenitor
cells, myoblasts [40].
Most histone mRNAs were produced at higher levels
in the proliferating myoblasts compared to myotubes
(Additional file 7: Figure S6A). This result was expected
because the myoblasts are replicating, while myotubes






































































Figure 8 Histone H2B variant levels in myoblast cells compared to myotube cells. (A) Proliferating myoblast (prolif) and differentiated myotube
cells (diff) were cultured in media containing heavy arginine, and samples were collected over the course of 7 days to monitor new histone
synthesis. Heavy (new) over light (old) levels for histone variants in proliferating or differentiated cells were plotted over time for two biological
replicates. (B) Relative abundances of histone H2B variants in myotubes (diff) versus (myoblasts). The abundance of each variant was summed
and divided by the abundance of all of the variants. Mean ± SE, n = 3.
Molden et al. Epigenetics & Chromatin  (2015) 8:15 Page 11 of 17however, was produced at significantly (P < 0.05) higher
levels in myotubes compared to myoblasts. This result is
in line with other studies that found that polyadenylated
H2B variants were produced at higher levels in non-
cycling cells [12]. Since polyadenylated H2B1D is synthe-
sized at higher levels in myotubes, we would then expect
that more heavy, newly synthesized H2B1D would be
incorporated into the chromatin compared to non-
polyadenylated variants. We would also expect that there
would be a higher percentage of H2B1D in the overall
H2B profile of myotubes compared to myoblasts.
The overall rate of heavy arginine incorporation was
much lower in non-dividing myotubes than in the prolifer-
ating myoblasts (Figure 8A). The histone variants H2A.Zand H1.x were labeled at a faster rate than all of the other
histones under both proliferating and differentiation
conditions, indicating a higher turnover (Figure 8A and
Additional file 8: Figure S7). All of the canonical histone
variants, including histone H2B, incorporated heavy argin-
ine at essentially the same rate (Figure 8A). In addition,
the relative abundances of different histone H2B variants
remained essentially unchanged between proliferating and
differentiated cells (Figure 8B).
Discussion
Through a combination of different mass spectrometry
methods, we identified all 13 H2B isoforms. We also iden-
tified H2B sequences modified with up to four acetylations,
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ubiquitination site. We described a bottom-up method
that can be used to consistently quantify the relative abun-
dances of nine H2B isoform N-terminal tail sequences
and their modifications from unfractionated histone sam-
ples. This same method can also be used to study the H2B
C-terminal tail and its modifications in a very straightfor-
ward and rapid manner.
There are variations in the levels of H2B isoforms and
their modifications in different cancer cell lines. Variations
in H2B isoform expression had been observed before in
quantitative PCR (qPCR) assays and microarray studies at
the mRNA level; however, this is the first investigation of
variations at the protein level. H2B isoforms are all located
in the histone gene clusters, facilitating their expression
during S-phase, but individual H2B genes have different
promoter sequences [41]. This means that individual H2B
genes may be regulated differently in cancer cell lines and
possibly in a tissue-specific manner. We found that cancer
cell lines from the same tissue exhibited similar H2B iso-
form profiles, so it is possible that H2B isoforms exhibit
tissue-specific profiles. The differences in H2B cancer cell
lines may alternatively result from chromosomal aberra-
tions or just from other abnormal gene regulation in
cancer cells. PANC cells consistently have an extra chro-
mosome 6 (containing histone clusters 1 and 2), U2OS
has rearrangements of chromosome 1 (containing histone
cluster 3), and HeLa cells have extra copies of chro-
mosomes 1 and 6 (ATCC.org). Regardless, differences
in H2B isoform expression between cancer cell lines
should be investigated further as controlling levels of
H2B may be important for maintaining histone levels
and maintaining a balance between histone family
members.
The most striking difference between the cell lines was
in the levels of H2B1B and H2B1M. Histone H2B1B only
differs from other H2B isoforms at two positions with an
alanine-to-serine difference and a valine-to-isoleucine dif-
ference, and it is unclear what affect these sequence varia-
tions would have on protein function. However, H2B1M
has much larger differences in sequence across four amino
acids in its N-terminal tail, including a threonine-to-
asparagine difference that is not present in any other H2B
isoforms. Differential expression of H2B1B had not been
identified before, but low-H2B1M expression was identi-
fied as a biomarker for breast cancer and gastric cancer
progression in microarray and proteomics studies [42,43].
Previous investigations of canonical H2A isoforms found
that up-regulation of specific H2A sequences in chronic
lymphocytic leukemia and in MCF-7 breast cancer cells
caused increased proliferation and carcinogenesis in those
cell types [44,45]. Similar studies should be performed by
overexpressing H2B1B and H2B1M in some of the cancer
cells where the levels of these variants are very low to seeif this causes a decrease in cancer cell proliferation or
progression.
We demonstrated that polyadenylated H2B mRNA is
produced independent of DNA replication. In this man-
ner, the H2B1D, H2B1K, and H2B2E isoforms that pro-
duce polyadenylated transcripts are similar to replication-
independent variants. However, histone production is not
independent of DNA replication at the protein level. After
blocking DNA synthesis in S-phase using a double-
thymidine block, there was very little synthesis of the
H2B1D protein despite continued production of its tran-
script. It is possible that the polyadenylated transcript level
is very low and does not contribute significantly to the
total H2B protein level. In fact, a previous study on polya-
denylated H2B2E found that polyadenylated H2B2E tran-
script levels were very low in normal cycling cells [38]. If
this is true, and the amount of protein being produced
outside of DNA replication is very low, then we may not
be able to measure the increase in H2B from replication-
independent production. It is also possible that the polya-
denylated H2B transcripts are not translated, and are
instead the result of aberrant histone 3′ end processing as
a result of missing cell-cycle-dependent histone mRNA
processing proteins [39,46,47], and that most histone pro-
duction in non-cycling cells comes from some basal his-
tone transcription that occurs throughout the cell cycle.
In non-cycling myotubes, all histone H2B isoforms turned
over at the same rate, suggesting no preference for any
sequence, regardless of whether it can be polyadenylated
or not. On the other hand, histone variants with genes
outside of the main clusters (for example H2A.Z and
H1.x) had different turnover profiles compared to the
replication-dependent variants in myoblasts and myo-
tubes, suggesting that there may be specific regulation
for these variants in myotubes.
Out of the three polyadenylated H2B isoforms, we
were only able to distinguish H2B1D from other H2B
isoforms using its N-terminal tail sequence and thus it
was the only form that could be quantified independ-
ently using bottom-up MS. H2B1K and H2B2E have the
same N-terminal tail sequence as H2B1C, and these vari-
ants can only be distinguished from other H2B by top-
down mass spectrometry using instruments with a higher
mass resolution than what is available in our lab, but it
would be interesting to see if they show the same trends
as H2B1D. In any case, H2B produced outside of the cell
cycle in HeLa cells is not as abundant as known H2A vari-
ants and probably does not have the same set of important
replication-independent functions.
Conclusions
We identified all 13 somatic H2B isoforms using a com-
bination of different mass spectrometry methods in the
most comprehensive study of H2B isoforms and their
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thod to quantify nine of the H2B isoforms using middle-
down MS. We applied this method to determine whether
any H2B isoforms have variations in expression levels
across cell types, are produced independently of cell cycle,
or are associated with specific interacting partners. We
found that the level of histone H2B isoforms, particularly
H2B1B and H2B1M, varies across cancer cell lines, sug-
gesting that H2B expression may be regulated differently
across cell types or possibly misregulated in cancer. We
also found that some H2B isoform genes can produce
polyadenylated mRNA independent of the cell cycle, but
these transcripts do to seem to be translated in significant
quantities outside of S-phase.
Methods
Cell culture
HeLa S3 cells were maintained in suspension in min-
imal essential Joklik’s modification medium (Sigma
Aldrich, St. Louis, MO, USA) with 10% newborn calf
serum (Invitrogen, Carlsbad, CA, USA) and penicillin-
streptomycin (pen-strep) solution diluted 1:100 (10,000
units penicillin G and 10 mg streptomycin per milliliter)
(Thermo Fisher Scientific, Waltham, MA, USA) and
supplemented with 1% Glutamax (Invitrogen, Carlsbad,
CA, USA). Jurkat, and HL60, cells were maintained in
RPMI-1640 (Mediatech, Inc., Manassas, VA, USA) me-
dium supplemented with 10% fetal bovine serum and
1:100 pen-strep, and PANC cells and U2OS cells were
grown in Dulbecco’s Modified Eagle’s Medium (DMEM;
Invitrogen, Carlsbad, CA, USA) supplemented with 10%
fetal bovine serum and 1:100 pen-strep, and PC3 cells
were grown in Ham’s F12-K media (Invitrogen, Carlsbad,
CA, USA) supplemented with 10% fetal bovine serum and
1:100 pen-strep. Data for the remaining cell lines were
analyzed using RAW data from a previous study in our
lab. Cell growth conditions, sample preparation, and mass
spectrometer parameters for the remaining cell lines can
be found in Leroy et al. (141).
For the cell cycle synchronization experiments, HeLa
cells were blocked in S-phase by adding 2 mM thymidine
to cells growing at a density of 3 × 105 cells/mL. The thy-
midine was removed for 9 h, followed by a second 17-h
block in 2 mM thymidine. Following synchronization,
cells were collected at 2, 4, 6, and 8 h and fixed in ethanol
and stained with propidium iodide for cell cycle analysis
by flow cytometry or snap-frozen and saved for q-RT-PCR
analysis.
For the cell cycle SILAC-labeling experiments, HeLa
cells were maintained in heavy arginine media with
10% dialyzed fetal bovine serum (FBS) and penicillin-
streptomycin solution diluted 1:100. The media was made
in-house using Joklik’s modification of Minimal Essential
Media Eagle formulation, replacing arginine in the mediawith the same concentration of stable-isotope-labeled
arginine (L-Arginine:HCl, 13C6,
15 N4, Cambridge Isotope
Laboratories, Andover, MA, USA). The cells were main-
tained in heavy media for 24 h and then blocked in
S-phase by adding 2 mM thymidine to the growth me-
dium. Cells were collected at time points before the
thymidine block and up to 24 h after the block to monitor
heavy arginine incorporation into histones.
Human myogenic cell line, LHCN M2, was a kind gift
from Dr. Woodring Wright (UT Southwestern Medical
Center at Dallas, Dallas, TX, USA). The immortalized
myoblasts were cultured in proliferation medium and, once
confluent, were differentiated in low-serum-containing
medium as described previously [48]. For heavy arginine
labeling of myoblasts and myotubes, the media-contained
DMEM was exchanged for one deficient in arginine and
lysine (Thermo Scientific, Waltham, MA, USA) supple-
mented with [13C6] L-Arginine (98% purity) (Cambridge
Isotope Laboratories, Tewksbury, MA, USA) and light
lysine and proline (Sigma Aldrich, St. Louis, MO, USA).
Similarly, dialyzed FBS (Invitrogen, Carlsbad, CA, USA)
was used instead of FBS (Invitrogen, Carlsbad, CA,
USA). Briefly, myoblasts grown in light proliferation
medium (day 0) were divided into two batches, one ex-
panded in heavy medium and the other in light medium.
Cells grown in heavy proliferation medium were har-
vested on days 1, 2, 3, and 7. Cells that grew confluent
in light proliferation medium (7 days) were switched to
heavy differentiation medium and harvested on days 1,
2, 3, and 7 using trypsin after washing with sterile PBS.
The cells were collected by centrifugation, washed in
PBS, snap-frozen in liquid nitrogen, and stored at −80°C.
Two biological replicates were used for histone analysis.
LHCN M2 cells were fixed 4 days after seeding for
myoblasts and 6 days after differentiation for myotubes,
and indirect immunofluorescence staining was performed
using 1:20 dilution of myosin heavy chain supernatant
(Developmental Studies Hybridoma Bank, cat# MF-20) as
primary antibody and anti-mouse Alexa Fluor 488 as sec-
ondary antibody. The images were visualized at 20×
in Nikon Inverted Microscope TE2000 and acquired
with Image Pro Plus 7.0, (Media Cybernetics, Rockville,
MD, USA).
q-RT-PCR
RNA was extracted from synchronized cells using TRIzol
(Invitrogen, Carlsbad, CA, USA). Five micrograms of
RNA was then treated with DNase I (NEB, Ipswich, MA,
USA) at 65°C for 1 h to remove contaminating genomic
DNA. cDNA was synthesized using random hexamer
primers and the Superscript III kit (Invitrogen, Carlsbad,
CA, USA). H2B isoforms were then quantified in each sam-
ple using isoform-specific primers and Sybrgreen master
mix (Invitrogen, Carlsbad, CA, USA). Two housekeeping
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drogenase (GAPDH)) were included in cell cycle analyses,
and three housekeeping genes (18S RNA, RORα, and
GAPDH) were included for normalization (primer se-
quences available upon request). PCR was performed
using 100 nM primers and the following cycling condi-
tions: 50°C for 2 min, 95°C for 10 min, followed by
40 cycles of 95°C for 15 s and 59°C for 1 min. A no-RT
control was also used to ensure that there was no con-
taminating DNA in the RT reaction; this is important
because H2B genes do not contain introns and so have
the same sequence as cDNA.
Histone extraction
Cells were harvested and washed twice using phosphate-
buffered saline. The cells were incubated in 10× the cell
pellet volume of nuclear isolation buffer (15 mM Tris–
HCl, 15 mM NaCl, 60 mM KCl, 5 mM MgCl2, 1 mM
CaCl2, 250 mM sucrose, pH 7.5, and 0.5 mM AEBSF,
10 mM sodium butyrate, 2.5 μM microcystein, 1 mM
DTT added fresh) with 0.3% NP-40 on ice for 5 min.
The nuclei were collected by centrifuging in a table-top
centrifuge at 500 × g at 4°C for 5 min. The resulting
nuclear pellet was washed twice with nuclear isolation
buffer without NP-40. After extracting the nuclei, his-
tones were extracted by re-suspending the nuclei in 5×
the nuclear pellet volume of 0.4 N sulfuric acid at 4°C
with rotation. The insoluble nuclear debris were pelleted
at 3600 × g at 4°C for 5 min, and the supernatant was
retained. Finally, histone proteins were precipitated on
ice for 1 h after adding 100% trichloroacetic acid to the
acid extraction supernatant at a ratio of 1:5 (v/v). The
precipitated proteins were washed once with 0.1% HCl
in acetone (−20°C), and then twice with acetone (−20°C),
then dried overnight on the bench-top.
RP-HPLC purification of histone H2B
Around 500 μg of acid-extracted histones were re-
suspended in 200 μL RP-HPLC buffer A (5% HPLC-
grade acetonitrile, 95% HPLC-grade water, 0.2% trifluor-
oacetic acid (TFA)) then loaded onto a Vydac 4.6 mm,
5 μm, 300 Å pore size column for 5 min at 2% RP-
HPLC buffer B (95% HPLC-grade acetonitrile, 5%
HPLC-grade water, 0.2% TFA) and resolved using a gra-
dient from 30% buffer B to 60% buffer B at a flow rate of
0.8 μL/min over 100 min. Fractions corresponding to
histone H2B were pooled and immediately dried in a
speed-vac.
Propionic anhydride derivatization
Acid-extracted histones or HPLC-purified H2B were re-
suspended in 20 μL 100 mM ammonium bicarbonate
(pH 8), and the final pH was adjusted to 8 using ammo-
nium hydroxide (28% to 30% ammonia basis, SigmaAldrich, St. Louis, MO, USA). The starting pH for the
propionic anhydride derivatization should be pH 8 and
not higher (cause of unwanted serine propionylation) or
lower (decreased reaction efficiency) to ensure that only
primary amines (lysines and protein N-termini) are deri-
vatized. After samples were set to pH 8, they were mixed
with 10 μL of a freshly prepared propionic anhydride
solution (75% isopropanol, 25% propionic anhydride) by
vortexing, and then, 5 μL of ammonium hydroxide was
immediately added to the mixture. More ammonium
hydroxide was added if the pH needed to be adjusted to
pH 8, then the samples were incubated at 37°C for
10 min. After incubation, the samples were dried in a
speed-vac to <10 μL to remove propionic acid formed as
a result of the reaction. The propionic anhydride deriva-
tization reaction was repeated one more time. After the
samples were dried to <10 μL, they were brought up to
50 μL using 10 mM ammonium bicarbonate (pH 8) and
digested with trypsin at a ratio of 1 μg trypsin:20 μg
sample for 6 to 8 h at 37°C. After the trypsin digest, the
samples were dried to 20 μL and subjected to two more
rounds of propionylation to cap peptide N-terminal
amines. Following propionylation, the samples were
de-salted using C18-StageTips [49] in preparation for MS
analysis.
Top-down H2B MS analysis
A linear triple quadrupole orbitrap (LTQ-Orbitrap) XL
mass analyzer (Thermo Fisher Scientific, Waltham, MA,
USA) was used for the initial top-down MS analyses of
HeLa and Jurkat H2B. The LTQ-Orbitrap XL was set to
have an automatic gain control (AGC) value of 5 × 105
for the FT full-MS scans and the FT MS/MS scans, the
HCD gas and the ‘FT zero offset’ were turned off, and
the detection delay was set to ‘low.’ Next, the LTQ ion
optics were tuned on the myoglobin 848.64 m/z ion to
improve ion transmission for large ions. The resolving
power of the Orbitrap was set to 30,000.
Top-down H2B analysis of other cancer cell lines was
performed on an Orbitrap Fusion instrument (Thermo
Fisher Scientific, Waltham, MA, USA). The AGC target
was set to 5 × 105, and the maximum injection time was
100 ms, for the Orbitrap when it was collecting both
full-MS and MS/MS spectra. A resolving power of 60,000
was used for full-MS scans and 30,000 for MS/MS scans.
The S lens voltage was set at 60%, and mild in-source frag-
mentation (around 40 V) was used to improve signal for
the high-m/z range and to reduce non-covalent adducts.
Pure histone H2B at a concentration of 1 μg/μL was
infused onto the mass spectrometer using a pulled, fused
silica tip (360-μM outer diameter, 50-μm inner diameter)
on a nano-ESI source at a flow rate of 0.7 μL/min using
a 50-μL syringe. The source voltage was set to 2.3 V for
both instruments. The histone H2B signal was averaged
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compass the most abundant charge states of histone
H2B. After recording the full-MS spectra for several mi-
nutes, H2B peaks were selected for fragmentation using
an isolation window of 3 m/z with no fragmentation to
record which species were being successfully isolated.
Next, the ETD reaction time was increased from 5 ms
until the optimal MS/MS signal and a wide range of
fragment ion masses were achieved. ETD spectra were
summed over 5 microscans, and the resulting spectra
were averaged over several minutes of collection time to
improve the signal.
Bottom-up LC-MS analysis
Samples were re-suspended in buffer A (0.1% formic
acid in LC/MS-grade water). Chromatographic separ-
ation of propionylated, digested histone or pure H2B
samples was performed on a 15-cm reversed-phase col-
umn packed with Magic C18 AQ resin (5 μm, 100 Å pore
size, Michrom Bioresources, Auburn, CA, USA) using a
flow rate of 0.25 μL/min on either an Easy-nanoLC
(Thermo Fisher Scientific, Waltham, MA, USA) or an
Eksigent nanoLC-Ultra 2D using a gradient from 1%
buffer B (0.1% formic acid in LC/MS-grade acetonitrile)
to 32% B over 42 min. The HPLC was coupled to either
an LTQ-Orbitrap Velos or an LTQ-Orbitrap Elite. The
mass spectrometer was operated in a semi-targeted
mode over three segments of the run. During the first
two segments, one full-MS spectrum was collected from
350 to 1,600 m/z, then five masses corresponding to his-
tone H4 and H3 acetylation states were targeted, and
the remaining scans were data-dependent CAD MS/MS
scans of the top six most abundant masses from the
full-MS scan. In the third segment, two full-MS scans
were collected: one from 350 to 1,600 m/z and one from
900 to 1,300 m/z, followed by data-dependent scans of
the top ten most abundant ions from the second, lim-
ited mass range full-MS scan. The AGC settings for the
mass spectrometers were set as follows: 3 × 105 for the
ion trap and 1 × 106 for the Orbitrap. The relative abun-
dance of histone H2B isoforms and their acetylated
forms was calculated based on the area under the ex-
tracted ion chromatograms from the limited mass-range
MS1 scan for all of the detectable charge states of each
H2B peptide.
RAW files of heavy-arginine-labeled histone samples
were loaded into Proteome Discoverer (version 1.4) for
analysis. The data was searched against a custom data-
base of 82 known human histone H3, H4, H2A, H2B,
and H1 and other chromatin-related protein sequences
using Mascot (version 2.2, Matrix Science, Boston, MA,
USA) in Proteome Discoverer. We set N-terminal propio-
nylation as a static modification and lysine propionylation
and acetylation as variable modifications. The enzyme wasset as Arg-C, and up to two missed cleavages were
allowed. Quantification was done through the event de-
tector and precursor ion quantifier nodes of Proteome Dis-
coverer. The search results and peak matches were
validated manually for H2B spectra using MS/MS spectra
and relative retention times as a guide, and some false-
positive peptide identifications were excluded from the
analysis. Results from each peptide were averaged. Only
peptides that are unique to a particular histone sequence
and that are known to not be heavily modified were used
in our analyses.
Additional files
Additional file 1: Table S1. Jurkat H2B isoform masses and
abundances detected by top-down MS. All of the H2B isoforms expressed
in human somatic cells are the same length and have very few points of
sequence variation. Consequently, many of them have the same intact
mass or masses that are similar enough that they cannot be resolved
based on the full-MS spectra alone.
Additional file 2: Figure S1. Characteristic proline-directed y ion
fragments in H2B(1–29) CAD spectra can be used to distinguish
sequences and PTM states. Characteristic proline-directed CAD fragment
ions (y20, y22, y23, y24) can be used to distinguish between isobaric
peptides (A) H2B1D(1 ac) and (B) H2B1N. ac = acetylation.
Additional file 3: Figure S2. Levels of acetylation on H2B isoform
N-terminal tails. The abundance of each modification for a peptide was
normalized against the total abundance of that peptide. Mean ± SE, n = 5.
Additional file 4: Figure S3. Alignment of the intact mass spectra of
RP-HPLC-purified H2B from different cancer cell lines. Top-down MS was
used to confirm that there are differences in the levels of H2B isoforms
across cancer cell lines.
Additional file 5: Figure S4. Confirmation of cells synchronization by
FACS analysis. Cells in G1-phase of the cell cycle have half the DNA and
therefore half of the propidium iodide staining of cells in G2/M-phase.
Over 90% of cells were synchronized at each cell cycle phase.
Additional file 6: Figure S5. Immunofluorescence microscopy images
(20×) of human myoblast cell line, LHCN M2, in proliferation medium
(A) and after culture in differentiation medium for 4 days (B). Actively
cycling myoblasts do not express myosin heavy chain (MHC) while on
differentiation, cells exit cell cycle, fuse into myotubes containing
multiple nuclei, and express MHC (Alexa Fluor-488, green).
Additional file 7: Figure S6. Comparison of H2B variant levels in
myoblasts versus myotubes by qPCR. (A) Relative fold difference of
histone mRNA in myoblasts (Prolif) versus myotubes (Diff). (B)
Polyadenylated H2B1D (H2B1DPa) mRNA fold difference in myoblasts
and myotubes. This is the same data as in (A), except with a restricted
y-axis to better visualize the results. The DCt values were calculated
by normalizing histone Ct values to the geometric mean of three
housekeeping genes (18S RNA, GAPDH, RORα). Replicate 1 and Replicate
2 are biological replicates. Mean ± SD, n = 3.
Additional file 8: Figure S7. Histone H2A and H1 variant levels in
myoblast cells compared to myotube cells. Proliferating myoblast (prolif)
and differentiated myotube cells (diff) were cultured in media containing
heavy arginine, and samples were collected over the course of 7 days to
monitor new histone synthesis. Heavy (new) over light (old) levels for
histone variants in proliferating or differentiated cells were plotted over
time for two biological replicates.
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